Navigation Links
Oncolytics Biotech Inc. Reports Highlights and Financial Results for 2007
Date:3/6/2008

nformation about Oncolytics please visit http://www.oncolyticsbiotech.com

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic; the Company's expectations as to the success of its research and development programs in 2008 and beyond, the Company's planned expansion, the value of the additional patents and intellectual property; the Company's expectations related to the applications of the patented technology; the ability of the technology to strengthen the core technology; the Company's expectations as to adequacy of its existing capital resources; the design, timing, success of planned clinical trial programs and the Company's planned expansion of such programs; and other statements related to anticipated developments in the Company's business and technologies involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statemen
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Media Advisory - Oncolytics Biotech Inc. to Present at Bio CEO & Investor Conference
2. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Radiation Therapy
3. Oncolytics Biotech Inc. Proceeds to Full Enrolment in U.S. Phase II Sarcoma Clinical Trial
4. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
5. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
6. Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
7. Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial
8. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
9. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
10. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
11. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
(Date:8/27/2014)... Raton, FL (PRWEB) August 27, 2014 ... are applied through the use of a handheld spray, ... across the United States. , The brand began ... unit. BIOEQUA researchers were surprised to learn that the ... be made extremely small and delivered directly to skin's ...
(Date:8/27/2014)... 27, 2014 Remcom announces an update ... new features for the biomedical industry. The central ... Thermal Sensor, exclusive to the Bio-Pro version of the ... XFdtd, developed to calculate the biological effects of electromagnetic ... added to all versions to expand engineers’ post-processing options. ...
(Date:8/26/2014)... they believe is the thinnest-possible semiconductor, a new ... three atoms thick. , The University of Washington ... semiconductor materials can be connected in an atomically ... could be the basis for next-generation flexible and ... solar technologies. , "Heterojunctions are fundamental elements of ...
Breaking Biology Technology:Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3BIOEQUA'S EQUA ESSENTIAL Product Line Redefines Skin Care & Now Available in America 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 2Remcom Announces Enhanced Biological Thermal Sensor and Other Biomedical Features in XFdtd EM Simulation Software Update 3Scientists craft atomically seamless, thinnest-possible semiconductor junctions 2
... at the University of Copenhagen has been chosen to ... Programme. The 2.5 million appropriation will aim to ... and the Nano-Science Center is the first Danish research ... Seventh Programme. , The goal of the research project ...
... - DuPont today congratulated,growers planting Pioneer(R) brand sorghum ... categories in the 2007 National Sorghum Producers, (NSP),Yield ... with Pioneer sorghum,hybrid 84G62., Farmers growing Pioneer ... contest segments. First-, second- and third-place national,honors were ...
... Diagnostics,Incorporated (NYSE: DGX ), the nation,s leading ... that its Board of,Directors declared a quarterly cash ... share, payable on January 23, 2008, to shareholders ... Diagnostics, Quest Diagnostics is the leading provider ...
Cached Biology Technology:DuPont Congratulates Growers Planting Pioneer(R) Brand Sorghum Hybrids in Winning Majority of National Categories in Yield Contest 2Quest Diagnostics Declares Quarterly Cash Dividend 2
(Date:8/27/2014)... greatest risk to Europe based upon a proxy for ... using a ,big data, approach to scientific research. , ... Global Health ranked the top 100 pathogens affecting humans ... system which, they believe, will help governments across the ... infectious diseases, including as a result of climate change, ...
(Date:8/27/2014)... exists as five strains, none of which have approved ... Sudan ebolavirus (SUDV). Although not the strain currently devastating ... recently as 2012. In a new study appearing in ... report a possible therapy that could someday help treat ... Jonathan Lai and colleagues explain that about 50-90 percent ...
(Date:8/27/2014)... health advocates, campaigns against trans-fats have largely succeeded ... taking aim at sugar for its potential contributions ... are still wrangling over the best way to ... an article in Chemical & Engineering News ... American Chemical Society. , In the article, Stephen ...
Breaking Biology News(10 mins):Big data approach identifies Europe's most dangerous human and domestic animal pathogens 2Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2
... is giving the VIP treatment to laboratory mice in ... , VIP is not "very important person," but vasoactive ... gut, that is also made by a specialized group ... Washington University assistant professor of Biology in Arts & ...
... Opening the door to a new way of understanding ... group of researchers at Scripps Institution of Oceanography at ... groundbreaking analysis of the North Pacific Ocean and how ... study, published in the May 19 issue of the ...
... Biocenter, University of Helsinki, show that atomic structures can ... as fossils did for the dinosaurs and reptiles. Their ... Molecular Cell. , These "molecular fossils" also revealed ... same structure. One plausible explanation may be that viral ...
Cached Biology News:Discovery clarifies role of peptide in biological clock 2Scripps scientists find potential for catastrophic shifts in Pacific ecosystems 2Scripps scientists find potential for catastrophic shifts in Pacific ecosystems 3
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... designer enzyme that enables RT-PCR in ... enzyme allows reverse transcription and PCR ... temperatures (65C), which helps to remove ... results in highly stringent, accurate annealing ...
... Lyophilized solid. Highly active enzyme useful ... of target substrates, and inhibitor screening. Specific ... is defined as the amount of enzyme that will ... hour at 37 C at saturated substrate concentrations. ...
Request Info...
Biology Products: